» Articles » PMID: 39403354

The Effects of IGF1 and MGF on Neural Stem Cells in Hypoxic Conditions

Overview
Specialty Neurology
Date 2024 Oct 15
PMID 39403354
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Ischemic stroke has high morbidity and mortality rates worldwide. Low oxygen (O) levels detected in such conditions create a vulnerable environment for neural stem cells (NSC), altering neuronal function, and leading to neuronal injury or death. There are still no effective treatments for such consequences. This study investigates the molecular and functional effects of growth factors, namely, insulin-like growth factor 1 (IGF-I) and mechano growth factor (MGF), in NSC exposed to low O levels.

Methods: An in vitro ischemia model was created by rat hippocampal NSC grown in culture that was exposed to varying oxygen levels, including 0%, 3%, and 20 % for the representation of anoxic, hypoxic, and normoxic conditions, respectively, during 24 h. NSC has investigated , , and gene expressions by real-time reverse transcription polymerase chain reaction. The effects of external administration of growth factors (IGF-I and MGF) on NSC proliferation in such conditions were explored.

Results: Increased and gene expressions were detected in the samples exposed to low O. Anoxia was the highest stimulant for and gene expressions. Meanwhile, HIF1-α that encodes hypoxia-inducible factor-1α revealed downregulation in relative gene expression fold change with IGF-I application in all conditions, whereas application upregulated its change in an anoxic environment. Furthermore, MGF-induced NSC had more proliferationmigration rate in all oxygen conditions. induced significant NSC proliferation in 0% and 20% O.

Conclusion: These findings suggest that IGF-I and MGF expressions were increased to reduce the damage in NSC exposed to low oxygen, and exogenous MGF and IGF-I application increased NSC proliferation at the time of injury. The results might imply the role of exogenous MGF and IGF-I in the treatment of ischemia for relieving the effect of neuronal damage due to their neuroprotective and proliferative effects.

References
1.
Decimo I, Bifari F, Krampera M, Fumagalli G . Neural stem cell niches in health and diseases. Curr Pharm Des. 2012; 18(13):1755-83. PMC: 3343380. DOI: 10.2174/138161212799859611. View

2.
Santilli G, Lamorte G, Carlessi L, Ferrari D, Nodari L, Binda E . Mild hypoxia enhances proliferation and multipotency of human neural stem cells. PLoS One. 2010; 5(1):e8575. PMC: 2797394. DOI: 10.1371/journal.pone.0008575. View

3.
Wang G, Semenza G . Purification and characterization of hypoxia-inducible factor 1. J Biol Chem. 1995; 270(3):1230-7. DOI: 10.1074/jbc.270.3.1230. View

4.
Ma Z, Xiang X, Li S, Xie P, Gong Q, Goh B . Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural compounds. Semin Cancer Biol. 2020; 80:379-390. DOI: 10.1016/j.semcancer.2020.09.011. View

5.
Jing X, Yang F, Shao C, Wei K, Xie M, Shen H . Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019; 18(1):157. PMC: 6844052. DOI: 10.1186/s12943-019-1089-9. View